Preparation of a Chicken scFv to Analyze Gentamicin Residue in

Subscriber access provided by University of Florida | Smathers Libraries

Article

Preparation of a chicken scFv to analyze gentamicin residue in animal derived food products Cui Li, Jinxin He, Hao Ren, Xiao-ying Zhang, Enqi Du, and Xinping Li Anal. Chem., Just Accepted Manuscript • DOI: 10.1021/acs.analchem.6b00426 • Publication Date (Web): 16 Mar 2016 Downloaded from http://pubs.acs.org on March 18, 2016

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Analytical Chemistry is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 27

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Analytical Chemistry

Figure 1. Agarose gel electrophoresis of the amplified antibody variable fragments. (A) Chicken spleen total RNA extraction. (B) PCR amplification of VH and VL. Lane 1 and 2: PCR products of VL, about 370bp. Lane 3 and 4: PCR products of VH, about 420bp. (C) Amplification of scFv by overlap PCR, about 750bp. 40x29mm (300 x 300 DPI)

ACS Paragon Plus Environment


1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Figure 2. Phage-ELISA. (A) The enrichment of specific scFv in each library after four rounds panning. (B) Binding activity of scFv antibodies to Gent. S-1—S-33: scFv antibodies from randomly selected clones from the 4th panning; C: blank control; N: negative control, BSA; P: positive control, IgY. 228x385mm (300 x 300 DPI)


Page 2 of 27

Page 3 of 27

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


Figure 3. Analysis of S-1 and S-5 by SDS-PAGE. (A) Lane 1 and 2: the S-1 induced and non-induced bacterium; lane 3 and 4: the S-5 induced and non-induced bacterium; lane 5 and 6: the pET-30a induced and non-induced bacterium. (B) Lane 1 and 2: the pellet and supernatant after bacterium cell disruption of S-1, lane 3 and lane 4: the pellet and supernatant after bacterium cell disruption of S-5; (C) Lane1 and 2: the denatured protein (scFv) of S-1 and S-5; lane M: unstained protein marker. 400x299mm (300 x 300 DPI)



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Figure 4. Standard curves of the competitive ELISA for Gent. X-axis logarithm concentration of Gent, Y-axis represents the inhibition rate (B/B0). B0 and B are the absorbance values obtained from binding at zero and certain concentrations of Gent standard. 282x211mm (300 x 300 DPI)


Page 4 of 27

Page 5 of 27

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


for TOC only 84x47mm (300 x 300 DPI)



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

84x47mm (300 x 300 DPI)


Page 6 of 27

Page 7 of 27

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


1

Preparation of a chicken scFv to analyze gentamicin residue

2

in animal derived food products

3

Cui Li, Jinxin He, Hao Ren, Xiaoying Zhang*, Enqi Du, Xinping Li

4

College of Veterinary Medicine, Northwest A&F University, Yangling, 712100,

5

Shaanxi, China;

6 7 8 9 10 11 12 13 14 15

*Corresponding authors

16

Dr. X.Y. Zhang, College of Veterinary Medicine, Northwest Agriculture and Forestry

17

University, Yangling, 712100, China Tel./Fax: +86 29 8709 1239. E-mail address:

18

[email protected].

19 20 21 22 23 24 25 26



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

27

Abstract: Chicken is an ideal model for simplified recombinant antibody library

28

generation. It has been rarely been reported to apply chicken single-chain variable

29

fragments (scFvs) in immunoassays for the detection of antibiotic and chemical

30

contaminants in animal food products. In this study, the scFvs (S-1 and S-5) were

31

isolated from a phage display library derived from a hyperimmunized chicken. The

32

checker board titration revealed that the optimum concentrations of S-1 and S-5 were

33

0.78µg/mL and 0.44µg/mL respectively, to obtain OD450 around 1.0 at 5µg/mL of

34

Gent-OVA coating concentration. Both S-1 and S-5 exhibited negligible cross

35

reactivity with kanamycin and amikacin. The 50% inhibitory concentration (IC50) of

36

S-1 and S-5 were 12.418ng/mL and 14.674ng/mL respectively. In the indirect

37

competitive ELISA (ic-ELISA), the limits of detection for S-1 and S-5 were

38

0.147ng/mL and 0.219ng/mL respectively. The mean recovery for Gent ranged from

39

60.91% to 118.09% with 10.35% relative standard deviation (RSD) between the

40

intra-assay and the inter-assay. These results indicate the chicken scFv based

41

ic-ELISA method is suitable for the detection of Gent residue in animal derived edible

42

tissues and milk.

43 44 45

Keywords: single-chain variable fragments (scFvs), gentamicin, ic-ELISA, chicken

46

IgY

47 48 49 50 51 52 53 54 55 56


Page 8 of 27

Page 9 of 27

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

57


Introduction

58

Gentamicin (Gent) is an aminoglycoside antibiotic commonly used to treat

59

Gram-negative bacterial infection1. It has been extensively used for treatment and

60

growth promotion in livestock management. The overuse of Gent in animal husbandry

61

could result into accumulation of its residues in animal derived foods2,3. The presence

62

of Gent residues in food has been considered as high risk for consumption due to its

63

adverse effects such as loss of hearing or of vestibular function (ototoxicity) and

64

impairment of renal function (nephrotoxicity)4,5. Besides, the overuse of gentamicin

65

promotes the emergence of antibiotic-resistant2. In order to monitor and control the

66

antibiotic abuse, the regulatory authorities in EU and China have established the

67

maximum residue limits (MRL) of gentamycin in food stuffs (Table 1) 6,7.

68

Table 1 MRL Values Established by the EU and China for Gentamicin of Veterinary Use (µg/kg)

Species of animal

Tissue

European Union (EU )

China

muscle

50

100

liver

200

2000

kidney

750

5000

fat

50

100

Bovine

milk

100

200

Chicken

edible tissue

N

100

Pig/bovine

69

N represents not established.

70

Numerous methods have been developed for the detection of gentamycin such as

71

chromatography8, LC-ES-tandem MS9, microbiological growth-inhibition assay10,

72

ELISA11, radioimmunoassay12, immunochromatographic assay13. The first three

73

methods are laborious, time-consuming, or in the need of sophisticated equipment.

74

Rests of the three methods (immunoassays) are widespread rapid screening techniques

75

because of specificity, sensitivity, low cost, and suitability for screening. ELISA is the

76

most commonly available method which is rapid, sensitive and simple for analysis of

77

various antibiotic residue or chemical contaminants. However, production of

78

polyclonal antibody has the limitations in terms of its standardization and



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

79

reproducibility, which make the recombinant antibody fragments (scFv, Fab) become

80

a credible alternatives. In consideration of the complex production process of

81

recombinant antibodies from mammal, chicken is an ideal model for simplified

82

recombinant antibody library generation owning to its unique mechanism in the

83

generation of antibody diversity. Meanwhile, avian has only one isotype of light chain

84

(lambda), as compared to two isotypes of light chain (kappa and lambda) in mammal.

85

Hence, the present study was aimed to develop a simple and quick method to prepare

86

recombinant antibody against Gent and develop a rapid detection method with high

87

sensitivity for analyzing gentamicin residue in animal-derived food.

88

Materials and methods

89

Chicken immunization

90

Two seven-weeks old White Leghorns chicken were first immunized with 250µg

91

of Gent-BSA with Freund’s complete adjuvant (FCA; Sigma-Aldrich Co., St. MO,

92

USA), then four booster injections with Freund’s incomplete adjuvant (FIA;

93

Sigma-Aldrich Co., St. MO, USA) were given at two weeks interval. Glutaraldehyde

94

method was employed to synthesize Gent-BSA as per the previously described

95

method11. Briefly, the mixture of 10.94mg of Gent and 15mg of BSA in 3mL of

96

phosphate buffer saline (PBS, 0.01M, pH 7.4) was stirred with 50µL of 25%

97

glutaraldehyde at 25°C for 16 h and centrifuged for 10min at 5000g. Then the

98

supernatant was dialyzed in PBS (0.01 M, pH 7.4) at 4°C for 72h and the dialysate

99

was renewed every 8h. At last, the Gent-BSA was obtained. A total of 1mL

100

immunogen contains 250µg of Gent-BSA in 500µL phosphate buffer saline (PBS)

101

with an equal volume of FCA or FIA was administered to each chicken

102

intramuscularly in four different sites of pectoral muscles.

103

RNA extraction and cDNA synthesis

104

On 7th day after the final immunization, the chickens were euthanized,

105

exsanguinated and the spleens were harvested. Total RNA was extracted from spleens

106

using RNAsimple Total RNA Kit (TIANGEN Biotech (Beijing) Co., Ltd). First-strand

107

cDNA was synthesized using HiScript Q Select RT SuperMix for qPCR (+gDNA

108

wiper) (Vazyme Biotech Co., Ltd).


Page 10 of 27

Page 11 of 27

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

109


RT-PCR and overlap PCR

110

First-strand cDNA (derived from the RNA extract obtained from the

111

Gent-immunized chicken spleen) was used to amplify heavy and light chain variable

112

fragment (VH and VL) genes using primers HF-Sfi I&HR-Linker for the VH region

113

or LF-Linker &LR-Not I for the VL region (Table 2) as described previously14. In

114

order to obtain the scFv fragments, the VH and VL which both contained the

115

sequence of a peptide linker were assembled by a second round of PCR (overlap PCR)

116

with the primers HF-Sif I&LR-Not I.

117

118

Table 2 Oligonucleotide primer sequences Primer

Oligonucleotide sequence

HF-SifI

ATGTCTATGGCCCAGCCGGCCGTGACGTTGGACG

HR-Linker

CAGAGCCACCTCCGCCTGAACCGCCTCCACCGGAGGAGACGATGAC

LF-Linker

TTCAGGCGGAGGTGGCTCTGGCGGTGGCGGATCGGCGCTGACTCAGCCGTCCT

LR-NotI

AGTTACTGGAGCGGCCGCACCTAGGACGGTCAGGG

Construction of scFv original library

119

The scFv fragments were digested with restriction enzymes Sfi I&Not I and

120

ligated with Sfi I/Not I digested pCANTAB5E vector using the T4 DNA Ligase

121

(Thermo Fisher Scientific Inc.). The ligated products were transformed into E. coli

122

TG1 cells. Serial dilutions of 10-1-10-6 were plated onto SOB plates (2% Tryptone,

123

0.5% Yeast Extract, 0.05% NaCl, 2.5mM KCl, 10mM MgCl2 and 1.5% Agar powder)

124

containing 100µg/mL ampicillin and 2% glucose (SOBAG) to determine the library

125

size. After inoculation, the SOBAG plates were incubated overnight at 30°C. The

126

next day 10 clones were randomly chosen and examined for scFv inserts by

127

colony-pick PCR. Then the colonies were scraped into 20mL 2YT (1.6% Tryptone, 1%

128

Yeast Extract and 0.5% NaCl), named the original antibody library and stored at -80℃

129

containing 20% glycerol.

130

Analysis and Sequencing the diversity of original antibody library

131

To analyze the diversity of original antibody library, ten clones which were

132

randomly chosen were BstO I (Promega Corporation) digested. Then the results of



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

133 134 135 136

BstO I restriction analysis were observed through agarose gel electrophoresis. The recombinant plasmids with scFv gene were sent to Invitrogen Corporation to sequence. Panning of phage displayed antibody libraries

137

The original antibody library was panned using a solid-phase protocol to select

138

scFvs with higher affinities. Briefly, for first three rounds of selection, 10µg of

139

Gent-OVA (the method of the synthesis of Gent-OVA was same as Gent-BSA) in the

140

Carbonate Buffer solution (CBS 0.05M, pH 9.6) was coated in each well of Corning

141

Maxisorb ELISA plate (1 x 8 Stripwell™) (Corning Inc., USA). In the last round of

142

selection, 5µg of Gent-OVA in the CBS was coated in each well. The plates were

143

incubated overnight at 4°C and next day unbound sites were blocked by 150µL (per

144

well) of 5% skimmed milk in PBS (PBSM) for 2h at 37°C. After washing, the PBSM

145

was replaced by 170μL of freshly prepared phage from the starting library of each

146

round of selection and the plates were incubated at 37°C for 2h to allow phage

147

binding. The unbound phages were discarded and the wells were firstly washed with

148

0.5% Tween–PBS (PBST) and PBS. The wells were washed five times in the first

149

round of selection, then 10 times for second and third round; and 15 times in the last

150

round. The bound phage were eluted by applying 150μL/well of HCl-glycine (0.2M,

151

pH 2.2) with gently shaking for 15min, the lower pH of the eluted phage was

152

neutralized with 150μL/well of Tris-HCl (1 M, pH 7.4). After each round of panning,

153

all the eluted phages were added to 8mL 2YT and cultured in shaker incubator at

154

30°C with 250rpm for 1h, and then the bacteria solution was taken out from shaker

155

incubator and stored at -80℃ with 20% glycerol, named second, third and fourth

156

antibody library respectively. 100µL of serially diluted (10-5-10-10) Phage-infected

157

log-phase bacterial cells from each panning were plated out onto each SOBAG plate

158

and cultured at 30°C for 16h. Then, the bacterial colonies were counted to determine

159

each library size after screening..

160

Phage ELISA

161

Phage-scFv suspensions from each round of selection against Gent-OVA were

162

tested using phage ELISA. In detail, taking out 50µL bacteria solution from each


Page 12 of 27

Page 13 of 27

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


163

antibody library was inoculated into 5mL of 2YT and cultured at 30°C for 3h with

164

shaking at 250rpm. Aliquots (50µL) were transferred into 5mL of 2YT containing

165

100μg/ml ampicillin, 2% glucose (2YT-AG) and 4×1012PFU of M13KO7 phages

166

were added. Culture medium was incubated at 37°C for 2.5h at 150rpm and then

167

centrifuged at 1,000g for 15min. The precipitate was resuspended in 400μL of

168

2YT-AK and cultured at 37°C overnight with shaking at 250rpm. The bacterial culture

169

solution was centrifuged and the phage-containing supernatant was collected for

170

phage ELISA analysis.

171

Corning Maxisorb ELISA plate was coated with 10μg of Gent-OVA per well in

172

100μl of CBS overnight at 4°C and then blocked with 150μL of PBSM for 2 h at 37°C.

173

Phage-scFvs were added to each well for incubating 2h at 37°C. The bound

174

phage-scFv was detected with horseradish peroxidase (HRP)-conjugated anti-M13

175

antibody (Amersham Pharmacia Biotech). The color was developed using TMB

176

(Promega Biotech Co., Ltd) for 10 min and the absorbance was read at 450 nm.

177

Expression and purification of the anti-Gent scFv protein

178

The target gene and pET-30a vector were digested by the Bgl II and Hind III

179

restriction enzyme (TaKaRa Biotechnology (Dalian) Co., Ltd.). After this, the scFv

180

fragments were inserted into pET-30a vector using the T4 DNA Ligase. Then the

181

positive recombinant plasmid was used to transform into E. coli strain BL21 (DE3)

182

and cultured in the Luria–Bertani (LB) medium (1% Tryptone, 0.5% Yeast Extract

183

and 1% NaCl) containing 100µg/mL kanamycin at 37°C. When the OD600 reached 0.7,

184

expression of the recombinant fusion protein was induced by 0.5mmol/L isopropyl

185

β-D-1-thiogalactopyranoside (IPTG) for 10h at 20°C.

186

Then the bacteria cells were collected by centrifugation at 12000g (America,

187

Beckman Avanti I-26 XPI) for 2min and re-suspended in 50mL PBS. Subsequently,

188

the pellets were sonicated (37%W, working 2s and pause 1s, total 20min). After the

189

liquid was centrifuged at 10000g for 1min and then the pellet and supernatant was

190

collected respectively. At last the pellet and supernatant was used to analyze the

191

solubility of the protein by SDS-PAGE.

192

Denaturation and renaturation of the anti-Gent scFv protein



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

193

The inclusion bodies were washed three times with PBS containing 0.1% Triton

194

X-100 and 2M urea at 3h interval. Subsequently, the inclusion bodies were solubilized

195

in 10mL 8M urea solutions by slowly stirring at 4°C overnight. To remove the

196

insoluble ingredient, the solubilized solution was centrifuged at 12000rpm for15min.

197

Finally, the solution containing the denatured scFv was dialyzed in PBS (pH 7.4) at

198

4°C over a period of 48h to make the urea been removed as much as possible from the

199

protein solutions.

200

Indirect competitive ELISA (ic-ELISA)

201

The checkerboard titration was used to determine the optimum concentration of

202

scFv and coating antigen for the ic-ELISA. The ic-ELISA was performed as described

203

previously15. Briefly, microtiter plate was coated with the optimum concentration of

204

Gent-OVA by overnight incubation at 4°C. The plate was washed two times with

205

PBST and two times with PBS; then, unbound sites were blocked by incubation with

206

5% PBSM at 37°C for 2 h. After washing, 100µL/well of scFv previously diluted with

207

PBS and a series of Gent standard concentrations (200, 100, 80, 50, 20, 10, 5, 2, 1 and

208

0.1ng/mL) was mixed, respectively. After incubation for 2h, the plates were washed

209

two times with PBST and two times with PBS, and 100µL/well of mouse anti-His

210

HRP-conjugated IgG (1/3000 dilution in PBS) was added. After incubation at 37°C

211

for 1h, the plates were washed three times with PBST and two times with PBS. Then

212

the TMB was added and incubated for 10min in the dark at room temperature and the

213

absorbance was read at 450nm.

214

A four-parameter logistic equation was used to fit the immunoassay data.

215

Calculations were performed using OrginPro 7.5 software (Origin Lab Corp.,

216

Northampton, MA, USA). The IC50 value, assay dynamic range, and limit of detection

217

(LOD) served as criteria to evaluate the ic-ELISA.

218

Cross-reactivity analysis

219

The specificity of the scFvs under optimized conditions was evaluated by

220

measuring cross-reactivity (CR) with a group of structurally related compounds,

221

including kanamycin, amikacin. In order to calculate the CR values, the IC50 values of

222

these compounds were compared with that of Gent. The equation is as follows:


Page 14 of 27

Page 15 of 27

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60


CR(%)=[IC50(Gent)/IC50(analyte)]×100%.

223 224

Sample Preparation

225

Milk, pork, beef and chicken samples were obtained from local market. For

226

recovery study, Gent (1000µg/mL, prepared in PBS) was added into each sample to

227

produce spiked concentration of 0, 50, 100 and 200μg/kg. It was performed as follows:

228

an aliquot of tissue sample (1g wet mass) was homogenized and transferred to a 50mL

229

polypropylene centrifuge tube. 5mL 5% trichloroacetic acid and 10mL of 0.2M PBS

230

was mixed with tissue sample. The mixture was then incubated for 30min at 60°C.

231

Subsequently, the suspension was centrifuged at 4000g for 15min at room temperature.

232

The supernatant was separated and 100μL of which was diluted with 900μL water.

233

Fifty microliter aliquots of the dilution were then pipetted into the microtiter plate for

234

analysis. After the Gent of different concentrations (0, 50, 100 and 200μg/L) was

235

added into milk sample, the milk samples were defatted by centrifugation at 4500g for

236

20min at 4°C. Then, after adding 60µL sodium nitroprusside (0.36mol/L) and 60µL

237

zinc sulfate (1.04mol/L) into 2mL of the defatted milk samples, the samples were

238

vortexed for 1min and then centrifuged at 4000g for 15 min at 4°C. The supernatant

239

was removed and diluted 10 times with PBS for analysis. The recoveries were

240

calculated on the basis of the standard curve constructed by ic-ELISA.

241

Results and Discussion

242

Construction of chicken scFv

243

Antibodies are ubiquitous tools in biotechnology. To date, different types of

244

antibodies, such as polyclonal antibody (pAb)15,16, monoclonal antibody (mAb),

245

recombinant antibodies (scFv and nanobody)17-19, specific to various antibiotics have

246

been produced. Alarmingly, there is an increasing concern among scientific

247

community that many antibodies could be unreliable reagents and the results of many

248

biomedical experiments cannot be reproduced due to the fact that traditional antibodies

249

have to rely on animals or cell lines, which can lead to the quality differentiation of

250

different batches of antibodies20,21. Instead, recombinant antibodies, especially the

251

scFv , with exact gene sequences are widely used in different biomedical purposes

252

with significant advantages on reproducibility over pAb or mAbs22.



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

253

Mice derived scFv was widely used initially. Because of the complex production

254

process of mice derived scFv, chicken derived scFv is served as an ideal recombinant

255

antibody to detect Gent in animal derived food products in this work. Chicken scFvs

256

are easier to make and chicken antibodies are ideal to use in the mammalian milieu as

257

they cross react less14. Chicken scFv combines both the high specificity and

258

homogeneity of the monoclonal antibodies as well as unique features of chicken

259

antibodies14,23. As a technical merit, in most cases, only one pair of primer is needed

260

to produce chicken scFv because both the heavy and light chain loci in chickens

261

consist of single functional variable region genes (V) and joining (J) region genes as

262

well as multiple diversity (D) segments that are very similar in the heavy chain locus

263

in mammal24. Using one pair primer not only saves time and resources, but also it can

264

reduce rare transcript loss due to the difference in the primer efficiencies25.

265

In this work, total RNA was isolated from spleen of immunized chickens (Figure

266

1A). After the synthesis of cDNA, The VH and VL fragments of the expected size

267

(about 420bp and 370bp) were amplified by PCR (Figure 1B). The scFv was

268

assembled with the VH, VL by overlap PCR using the primers as described above

269

(Figure 1C).

270

Figure 1 is here

271

In the process of producing specific scFv, the diversity of the phage-antibody

272

library is of great importance. However, there is no need to concern the diversity in

273

the production of chicken antibodies, chicken possess a diversity generating process

274

that is distinctly unique compared to mammals26. Chicken use a gene conversion

275

strategy to create a diverse antibody repertoire, it makes the genes undergo a single

276

V(D)J recombination event, which were followed by gene conversion utilizing

277

multiple upstream V-region pseudogenes14,26. In this work, the results of PCR

278

indicated that positive rate of insertion of phage clones could reach at 90% (Figure

279

S-1, see Supporting Information section). According to different length of the

280

fragments after the BstO I digesting and the sequence alignment with chicken

281

germline gene (Supporting Information section), the diversity of antibody library

282

reaches about 80%, which could meet the subsequent antibody screening work.


Page 16 of 27

Page 17 of 27

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

283


Panning of phage displayed antibody libraries

284

In order to obtain highly specific antibodies from the scFv original library (the

285

size of original library was 2.27×107), we applied a strategy where the washing steps

286

were progressively increased while the concentrations of coated Gent-OVA were

287

decreased from 10µg/well to 5µg/well (Table 3)27. After four rounds of panning,

288

phage-ELISA had been done to evaluate the enrichment of specific scFv in each

289

library. The result indicated that the degree of enrichment of the specific scFv

290

increased gradually except the fourth round panning (Figure 2A), it could be triggered

291

by the sudden decrease of the amount of coating antigen. The size of anti-Gent scFv

292

antibody library of each panning was displayed using output (Table 3). Result

293

indicates that, our panning strategy was effective in isolation of positive scFv clones.

294

Thirty-three phage clones randomly chosen from the fourth round of panning were

295

analyzed by phage ELISA (Figure 2B). A total of 12 clones were sequenced in our

296

study, and they have been supplemented in the Supporting Information section.

297

Table 3 The library size and phage titer of each panning Coated

Coating

Rounds

298 299

Output Input

Output/Input

antigen

concentration/well

(titer)

1

Gent-OVA

10µg

4×1011

3.7×105

9.25×10-7

2

Gent-OVA

10µg

4×1011

6.7×106

1.675×10-5

3

Gent-OVA

10µg

4×1011

3.71×109

9.275×10-3

4

Gent-OVA

5µg

4×1011

1.65×109

4.125×10-3

Figure 2 is here Expression, purification, and identification of the anti-Gent scFv

300

Among the 33 phage clones, two clones (S-1 and S-5) were used to subsequent

301

expression. A 35kDa band was detected by SDS-PAGE whereas this band appeared in

302

both the induced and non-induced cell culture (Figure 3A). The analysis of solubility

303

indicated that expressed scFv protein existed as inclusion bodies (Figure 3B). Then

304

the inclusion bodies were washed using 2 M urea at 4°C. Subsequently, the inclusion

305

bodies were solubilized by slowly diluting the purified protein in 8M urea at 4°C

306

overnight. Finally, the denatured/purified protein was renatured by dialysis in PBS



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 18 of 27

307

(pH 7.4) at 4°C over a period of 48 h and the urea was as much as possible to remove

308

from the protein. The purity of protein solution was confirmed by SDS-PAGE (Figure

309

3C), and then the purified protein was stored at −20°C. Figure 3 is here

310 311

Indirect competitive ELISA (ic-ELISA) for constructing the standard curve

312

The purified S-1 and S-5 were evaluated for their performance by ic-ELISA. The

313

optimum concentrations of S-1 and S-5 were 0.78µg/mL and 0.44µg/mL respectively

314

to obtain OD450 around 1.0 at 5µg/mL of Gent-OVA coating concentration by the

315

checkerboard titration. Under these optimal conditions, the regression curve equations

316

of

317

y=0.76066-0.23479x (R2=0.97475) respectively as shown in Figure 4. The IC50 values

318

of the assay established with S-1 and S-5 were 12.418ng/mL and 14.674ng/mL

319

respectively. The IC50 demonstrated that, the scFv could be used to detect the Gent.

320

The linear range of the assay established with S-1 and S-5 were 0.147 to

321

204.165ng/mL and 0.219 to 208.459ng/mL respectively.

the

the

S-1

S-5

were

y=0.74407-0.23033x

(R2=0.9849)

and

Figure 4 is here

322 323

and

Cross-Reactivity

324

Owning to the advantage of antibody fragments, scFv could better recognize

325

some antigen-antibody binding sites which are partially obscured from antibody

326

recognition by the associated the three-dimensional carbohydrate structures of antigen,

327

as compared to macromolecular antibodies28. Thus, the cross-reactivity of the scFvs

328

with kanamycin and amikacin was tested by ic-ELISA. Result indicated that, the S-1

329

and S-5 showed very low cross-reactivity with other aminoglycosides (kanamycin and

330

amikacin), indicating that the scFv is highly specific for Gent (Table 4).

331

Table 4 Cross-reactivity of anti-Gent scFvs with various aminoglycoside antibiotics

Analytes

ScFvs

Cross-reactivity (%)

S-1

100

S-5

100

S-1

Preparation of a Chicken scFv to Analyze Gentamicin Residue in

Recommend Documents